Family Medicine Doctors in Miller Place, NY Accepting Medicare

4 Family Medicine doctors found. Showing 1 - 4

Dr. Mark David Wasserman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Route 25a, Miller Place, NY 11764 Phone: 631-744-6666    Fax: 631-744-0525

Dr. Joseph Michael Venezia, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 765 Route 25a, Miller Place, NY 11764 Phone: 631-821-0505    Fax: 631-821-5065

Dr. Ivy D Chung, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 765 Route 25a, Miller Place, NY 11764 Phone: 631-821-0505

Dr. Mark Alan Koenig, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 765 Route 25a Ste 6, Miller Place, NY 11764 Phone: 631-320-3200    Fax: 631-350-7798

News Archive

Acute liver failure after massive hepatectomy improves with liver cell transplantation

Liver failure often occurs after an extensive hepatectomy, which is the surgical resection of the liver. While liver cell transplantation is a useful therapy for acute liver failure after massive hepatectomy, when cells are transplanted through liver portal veins raises the risk of embolization, such as the formation and movement of a blood clot, often with fatal consequences.

DE-MRI before ablation can stage atrial fibrosis and help predict success treatment

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).

Lake B2B releases new version of 360° healthcare marketing platform

It is early 2015 and Lake B2B has good news for Healthcare marketers. A leader in providing data centric solutions, Lake B2B has launched its 2015 version of 360° marketing platform for healthcare marketers. This self-service login enables marketers to search 10 Million Healthcare Database, create email templates on the fly and launch email and nurturing campaigns with a click.

Bacteria in urine could contribute to overactive bladder

Bacteria live in the bladders of healthy women, discrediting the common belief that normal urine is sterile. This finding was presented today by researchers from Loyola University Chicago at the 114th General Meeting of the American Society for Microbiology in Boston.

Read more Medical News

› Verified 5 days ago